About CVRx, Inc.
CVRx, Inc. is a privately held company founded in 2001 and headquartered in Minneapolis, USA. Our vision is to advance health for people everywhere, giving each patient a fuller life. CVRx pioneer’s unique therapies that harness and harmonize the body's natural systems, benefiting society and making CVRx a universal role model in healthcare.
CVRx manufactures BAROSTIM NEO™, the only device CE Marked for the separate indications of heart failure and resistant hypertension. Currently, BAROSTIM NEO™ is commercially available in over 20 countries and under clinical evaluation for the treatment of heart failure and hypertension in the United States.
About Baroreflex Activation Therapy
Baroreflex Activation Therapy (BAT) is a neuromodulation therapy that is designed to trigger the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure. It is delivered through a long-lasting implant system, the BAROSTIM NEO™, which can be customized to each patient's individual therapy needs. CVRx™ has developed BAROSTIM NEO™ as part of its vision to advance health for people everywhere, giving each patient a fuller life.